PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group Inc., announced the acquisition of the pharma business of Isochem SAS of France.
This is a fully integrated business comprised of research, product/process development, regulatory approvals, pilot scale and full plant-scale production of drug intermediates and active pharma ingredients (APIs) for major pharmaceutical companies worldwide to serve the needs of Oncology, Cardiovascular, Infectious, Gastro-Intestinal, Neurology and rare diseases. These facilities with combined footprint of over 40 acres are located at three sites — Gennevilliers, Pithiviers, and Vert-Le-Petit — within a 60 miles radius of Paris. The facilities, which are all cGMP US-FDA audited plants for manufacturing pharmaceutical products, will henceforth forth be called “PMC Isochem SAS” and the latter with 230+ employees will operate as a wholly owned subsidiary of PMC Group France.
“This acquisition, coming within two months of the acquisition of the Hyderabad, India-based pharma company YM Drugs and Chemicals by PMC Group International, puts the latter in a solid position to serve all the regulated pharma markets around the world with cost-effective offerings of proprietary drugs, drug intermediates, and custom drug research & manufacturing services for a wide range of disease categories,” said Dr. Raj Chakrabarti, Executive Vice President of PMC Group International.
Source: PMC
The future CEO of thyssenkrupp Uhde, Nadja Håkansson, has held various management positions at Siemens and Siemens Energy and looks back on over 18 years of national and international experience in the areas of supply chain management, operations, sales and corporate management.
Neste and South Korean company Lotte Chemical have partnered on a project to elevate the sustainability profile of chemicals and plastics. The partnership’s ambition is to replace fossil resources with renewable raw materials that offer a lower carbon footprint.
At least the confidence in the chemical sector has been seeing an upward trend and the trade balance is recovering as destocking seems to be coming to an end. Citing projections from the European Central Bank, CEFIC states that the level of inflation is expected to fall from 5.4% in 2023 to 2.3% in 2024.
